![Philippe Duchateau](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 181 735 $ al 31/08/2026
Philippe Duchateau currently works at Cellectis SA, as Chief Scientific Officer from 2012.
Dr. Duchateau received his doctorate degree in 1993 from the University of California.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
CELLECTIS S.A. 0,07 % | 15/02/2026 | 53.324 ( 0,07 % ) | 181 735 $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| CELLECTIS S.A. | Director Técnico/Científico/I+D | 01/04/2001 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 2 |
|---|---|
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
University of California
 University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
